Correvio Pharma Corp.

TSX Exchange | Jan 23, 2020, 11:24 AM EST | Real-time price

CORV $ 0.48 RT
-0.02 (-4.00%)
Day Low: 0.48
Day High: 0.48
Detailed Quote
Open: 0.48
High: 0.48
Beta: 0.7225
Listed Shares Out.1: 55,382,228
Total Shares (All Classes)2: 50,521,375
Prev. Close: 0.50
Low: 0.48
VWAP: 0.48
Market Cap1: 26,583,469
Market Cap (All Classes)2*: 24,250,260
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -1.21
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 12.00
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial Fibrillation, Hospital Acquired Pneumonia & Community Acquired Pneumonia, Pulmonary Arterial Hypertension, and Su... More

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.